Patient safety is our top priority, and we are committed to supporting the active fight against falsified Novo Nordisk medicines and other illegal activity in the market.

We are proactively combating falsified medicines. Through constantly reinforced security measures and collaboration with authorities and industry peers, we strive to protect patient’s health and ensure the integrity of our products.

We are committed to raising awareness about and combating the manufacturing and spread of unauthorised, unlawful and unsafe semaglutide active pharmaceutical ingredients (APIs) and semaglutide medicines, as well as other illegal activities that threaten patient safety and the integrity of our products.